Credit: Getty Images In the US, the proportion of men receiving HRR testing peaked at 55.5% in 2020 and decreased to 49.4% in 2022. From 2014-2022, only about 38% of men with metastatic ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

'While chemo and radiation have ended, I'm still undergoing other treatments while raising money for research and awareness of genetic testing.' As soon as I received the diagnosis of Stage 2 breast ...

The American College of Medial Genetics and Genomics (ACMG) announced today that press registration is now open for the  2026 ...

Please provide your email address to receive an email when new articles are posted on . The use of chatbot tools may be a valuable part of health management strategies to improve access to cancer ...